AVTR
Avantor, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum-inputs (vergelijkbare managers):
breedte van houders -14.3% ·
aandelenstroom +1.5% ·
netto nieuwe posities -16.7%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | -6 | 446.16M | $4.42B | +7 | −12 |
| Q1 2026 | 122 | +8 | 424.30M | $3.33B | +12 | −5 |
| Q4 2025 | 115 | -2 | 476.25M | $5.46B | +2 | −3 |
| Q3 2025 | 19 | -2 | 316.38M | $3.95B | — | −3 |
| Q2 2025 | 19 | +1 | 314.56M | $4.23B | +2 | −1 |
| Q1 2025 | 15 | +2 | 151.43M | $2.45B | +3 | −1 |
| Q4 2024 | 13 | 0 | 143.08M | $3.01B | +2 | −2 |
| Q3 2024 | 12 | -2 | 93.20M | $2.41B | +1 | −3 |
| Q2 2024 | 14 | — | 91.78M | $1.95B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 68.42M | +4.7% | $1.77B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 11.15M | +7.1% | $287.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 11.15M | +7.1% | $287.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Norges Bank ✦ (passief) | 8.09M | -0.3% | $209.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Millennium Management ✦ | 2.02M | -21.1% | $52.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.62M | -18.3% | $41.84M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.62M | -18.3% | $41.84M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.02M | +19.3% | $26.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.02M | +19.3% | $26.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 536.73K | -2.3% | $13.89M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 536.73K | -2.3% | $13.89M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 219.59K | -19.6% | $5.68M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 219.59K | -19.6% | $5.68M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 37.13K | +168.2% | $960,579 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 30.95K | -86.7% | $800,677 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 30.62K | Nieuw | $792,165 | 0.0% | New | 1 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 29.54K | -49.7% | $764,252 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Two Sigma Investments | $792,165 | 0.0% |
Verlaten
| Adage Capital Partners | $21.20M | was 0.0% |
| Soros Fund Management | $6.36M | was 0.2% |
| Marshall Wace | $1.41M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 428 houders, 673.97M aandelen, $5.11B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.